Clinical Trials Directory

Trials / Completed

CompletedNCT00481104

Evaluation of Long Term Safety of Tesofensine in Patients With Obesity

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
140 (actual)
Sponsor
NeuroSearch A/S · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Purpose of the study is to evaluate the long term safety of tesofensine in obese patients

Conditions

Interventions

TypeNameDescription
DRUGTesofensine

Timeline

Start date
2007-05-01
Primary completion
2008-09-01
Completion
2008-11-01
First posted
2007-06-01
Last updated
2011-07-04

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00481104. Inclusion in this directory is not an endorsement.

Evaluation of Long Term Safety of Tesofensine in Patients With Obesity (NCT00481104) · Clinical Trials Directory